Cyril Quivoron

Years Active: 2018-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Fabio Andreozzi, Matteo Dragani, Cyril Quivoron, Fabien Le Bras, Tarek Assi, Alina Danu, Karim Belhadj, Julien Lazarovici, Sophie Cotteret, Olivier A Bernard, Vincent Ribrag, Jean Marie Michot
Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study. Cancers 15 (5) (2023)
Fabio Andreozzi, Matteo Dragani, Cyril Quivoron, Fabien Le Bras, Tarek Assi, Alina Danu, Karim Belhadj, Julien Lazarovici, Sophie Cotteret, Olivier A Bernard, Vincent Ribrag, Jean Marie Michot
Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study. Cancers 15 (5) (2023)
Lynn Quek, Muriel D David, Alison Kennedy, Marlen Metzner, Michael Amatangelo, Alan Shih, Bilyana Stoilova, Cyril Quivoron, Mael Heiblig, Christophe Willekens, Véronique Saada, Samar Alsafadi, M S Vijayabaskar, Andy Peniket, Oliver A Bernard, Sam Agresta, Katharine Yen, Kyle MacBeth, Eytan Stein, George S Vassiliou, Ross Levine, Stephane De Botton, Anjan Thakurta, Virginie Penard-Lacronique, Paresh Vyas
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib. Nature medicine 24 (8) (2018)

Cyril Quivoron.css-eqlu8i{font-size:small;padding-left:4px;}